Edition:
United States

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

17.96USD
8 Dec 2017
Change (% chg)

$0.01 (+0.06%)
Prev Close
$17.95
Open
$17.95
Day's High
$18.02
Day's Low
$17.70
Volume
75,766
Avg. Vol
59,966
52-wk High
$25.09
52-wk Low
$14.79

Latest Key Developments (Source: Significant Developments)

Atricure reports Q3 loss per share $0.22
Wednesday, 1 Nov 2017 04:05pm EDT 

Nov 1 (Reuters) - Atricure :Atricure reports third quarter 2017 financial results.Q3 revenue $42.2 million versus I/B/E/S view $43.4 million.Q3 loss per share $0.22.Sees FY 2017 revenue up about 11 to 13 percent.Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.Atricure Inc - for 2017 ‍net loss per share is projected to be in range of $0.94 to $1.04​.Atricure Inc - ‍company continues to expect positive adjusted EBITDA for full year 2018​.  Full Article

Atricure Q2 loss per share $0.21
Thursday, 27 Jul 2017 04:05pm EDT 

July 27 (Reuters) - Atricure ::Atricure reports second quarter 2017 financial results.Q2 revenue $45.2 million versus i/b/e/s view $44.2 million.Q2 loss per share $0.21.Q2 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S.Atricure inc - ‍raising low end of revenue range on its previously given, full year 2017 financial outlook​.Atricure inc - for 2017 ‍constant currency revenue growth expected to be about 14% to 15% , a range of $177 million to $178 million at current exchange rates​.Atricure inc - ‍continues to expect positive adjusted ebitda for full year 2018​.Atricure inc -2017 ‍net loss per share is projected to be in range of $0.94 to $1.04​.  Full Article

Atricure Inc reports Q1 loss per share $0.32
Thursday, 4 May 2017 04:05pm EDT 

May 4 (Reuters) - Atricure Inc :Atricure reports first quarter 2017 financial results.Q1 revenue $41.3 million versus I/B/E/S view $40.3 million.Q1 loss per share $0.32.Q1 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S.Company reiterates its previously given, full year 2017 financial outlook.Company continues to expect positive adjusted EBITDA for full year 2018.  Full Article

Atricure Q4 loss per share $0.27
Tuesday, 28 Feb 2017 04:03pm EST 

Atricure Inc : Atricure reports fourth quarter and full year 2016 financial results . Q4 revenue $41.2 million versus I/B/E/S view $42 million . Sees FY 2017 loss per share $0.94 to $1.04 . Q4 loss per share $0.27 . Sees FY 2017 revenue up about 13 to 15 percent . Q4 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S . FY 2017 earnings per share view $-0.87, revenue view $177.6 million -- Thomson Reuters I/B/E/S .Atricure Inc - continues to expect positive adjusted ebitda for full year 2018.  Full Article

AtriCure announces preliminary results for Q4 and FY 2016
Monday, 9 Jan 2017 08:00am EST 

AtriCure : AtriCure announces preliminary results for fourth quarter and full year 2016 . Sees FY 2017 loss per share $0.88 to $0.96 . Sees FY 2017 revenue up about 13 to 15 percent . Sees FY 2016 revenue $155.1 million .AtriCure Inc- Preliminary and unaudited revenue for Q4 2016 is expected to be approximately $41.2 million.  Full Article

Atricure sees FY 2016 revenue up about 20 to 22 percent
Thursday, 4 Aug 2016 04:01pm EDT 

Atricure Inc : Atricure reports second quarter 2016 financial results . Sees fy 2016 revenue up about 20 to 22 percent . Q2 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S . Q2 revenue $39.7 million versus i/b/e/s view $39.8 million . Q2 loss per share $0.26 .Fy2016 revenue view $160.5 million -- Thomson Reuters I/B/E/S.  Full Article

AtriCure, Inc announces $25 mln term loan
Thursday, 28 Apr 2016 04:01pm EDT 

AtriCure, Inc:Says has entered into an amended and restated term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to a new $25 mln five-year term loan, as well as renewing a $15 million revolving line of credit.  Full Article

AtriCure Inc updates FY 2016 guidance
Monday, 11 Jan 2016 08:00am EST 

AtriCure Inc:Projects FY 2016 revenue growth of about 25 pct. over FY 2015 at current exchange rates.Expects FY 2016 adjusted EBITDA, a non-GAAP measure, is projected to be a loss in the range of $14 to $15 million.  Full Article

BRIEF-Atricure reports Q3 loss per share $0.22

* Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S